Reduced Risk in Melanoma and Nonmelanoma Skin Cancers in Obese Patients on Semaglutide and Tirzepatide.
Alameddine R, Roecker A, Jabin M, Wagner RF
Dermatologic SurgeryIn the feed 9 Sep 2026, published online 10 Sep 2026, issue 2026 Sep 10, added to PubMed 9 Sep 2026
Topics: Skin cancer & tumors
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42714323 · DOI 10.1097/DSS.0000000000005339